- Short-term Therapy with Pegylated Interferon plus Ribavirin for the Chronic Hepatitis C Genotype 2 Patients
-
Jung EU, Park JH, Pae KI, Kang SW, Park SJ, Jee SR, Park ET, Lee YJ, Lee SH, Seol SY
- KMID: 760735
- Korean J Hepatol.
- 2007 Sep;13(3):341-348.
- doi: 10.3350/kjhep.2007.13.3.341
BACKGROUND/AIMS: The standard treatment for chronic hepatitis C patients infected with HCV genotype-2 is a combination of pegylated interferon alfa and ribavirin over a 24 week period. It is... -
- CITED
-
- Close
- SHARE
-
- Close
- A comparison of 24- vs. 48-week peginterferon plus ribavirin in patients with genotype 1 chronic hepatitis C
-
Kim MN, Yoon KT, Park JY, Kim DY, Ahn SH, Chon CY, Han KH
- KMID: 1384057
- Korean J Hepatol.
- 2009 Dec;15(4):496-503.
- doi: 10.3350/kjhep.2009.15.4.496
BACKGROUND/AIMS: The standard therapy for patients with genotype 1 chronic hepatitis C (CHC) is a combination of peginterferon and ribavirin for 48 weeks. However, the most appropriate duration of treatment... -
- CITED
-
- Close
- SHARE
-
- Close
